64
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Linear-quadratic analysis of tumour response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts

Pages 197-205 | Published online: 03 Jul 2009
 

Abstract

Purpose: To compare values for the alpha / beta ratio in experimental tumours irradiated either under conditions of clamping and short overall time or under more 'clinically realistic' conditions. Materials and methods: Human squamous cell carcinomas, FaDu and GL, were grown in nude mice. alpha / beta values were determined from local tumour control data after treatment with single doses and 2, 4, and 8 fractions under clamp hypoxia in 3.5 days, using maximum likelihood analysis. Effective alpha / beta values (alpha / beta) were determined from treatment with 12, 30, and 60 fractions under ambient conditions in a constant overall treatment time of 6 weeks. Results: After correction for an oxygen enhancement ratio of 2.7 the alpha / beta values were 15 Gy (95% CI 9; 24) for FaDu and 49 Gy (26; 122) for GL. In FaDu the TCD values after 12 to 60 50 fractions were not significantly different, the alpha / beta value was eff infinite (52; inf.). Unexpected from the high alpha / beta value, the TCD values of GL tumours increased from 37 Gy (28; 47) after 50 12 fractions to 59 Gy (52; 67) after 60 fractions: the alpha / beta value eff was 3 Gy (0.6; 12 Gy). Conclusions: The results support the view that mechanisms other than recovery from sublethal radiation damage and repopulation of clonogenic tumour cells may importantly impact on treatment outcome when the number of fractions is changed in clinical radiotherapy. eff

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.